Search Results 71-80 of 17068 for Bronchopulmonary
The primary objective of the study is to compare sacituzumab tirumotecan combined with pembrolizumab to pembrolizumab alone with respect to overall survival (OS) ...
Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The primary objective of the study is to compare sacituzumab tirumotecan combined with ...
... bronchopulmonary dysplasia. Respirol Case Rep. 2023 Sep; 11 (9):e01203 Epub 2023 Aug 16. View PubMed; Wadiwala IJ, Fernandez-Bussy S, Garg P, Ali M, Feinglass ...
Learn about the expertise and wide range of services at Mayo Clinic for people with complex or serious conditions that affect the lungs and breathing.
The purpose of this study is to ensure technical success in the treatment of assessing diaphragmatic neuromuscular junction (NMJ) function of the diaphragm in ...
About this study. The purpose of this study is to decipher clinical, imaging, immune, molecular and/or viral traits underlying post-acute COVID-19 lung ...
The purpose of this study is to evaluate the effietiveness of remdesivir (RDV) in reducing the rate of of all-cause medically attended visits (MAVs; ...
The primary objective of the study is to compare sacituzumab tirumotecan combined with pembrolizumab to pembrolizumab alone with respect to overall survival ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.